We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Cyntellect Appoints Saiid Zarrabian as CEO

Cyntellect Appoints Saiid Zarrabian as CEO

Cyntellect Appoints Saiid Zarrabian as CEO

Cyntellect Appoints Saiid Zarrabian as CEO

Read time:

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Cyntellect Appoints Saiid Zarrabian as CEO"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Cyntellect, Inc., a privately-held life sciences company commercializing products to advance life science and stem cell research, biopharmaceutical production, and drug discovery, announced the appointment of Saiid Zarrabian as President & CEO.

A senior life sciences executive with strong leadership and operations experience in both public and private companies, Zarrabian has experience spanning the biotechnology, pharmaceutical, and chemical, hardware and tools and services sectors. Zarrabian replaces Fred Koller, Ph.D., who has assumed the position of Cyntellect’s Chief Technology Officer.

“Saiid has spent his entire career working to advance scientific innovation and entrepreneurship. His experience and leadership will be invaluable as Cyntellect advances its high value technology and award winning products into our customers’ research and development processes and emerging commercial applications,” said Cyntellect co-founder Dr. Koller.

Mr. Zarrabian has been consulting with the company and has been acting CEO since March of 2010. He previously served as President and COO of Synomyx, a biotechnology company focused on the discovery and commercialization of new flavors ingredients, as COO of Pharmacopeia, a leading provider of combinatorial chemistry discovery services and compounds, and President and COO of Molecular Simulations, a company providing software, databases and custom services for pharmaceutical and chemical industries.

Most recently, he has performed executive consulting services for a variety of small- to mid-sized companies including BioBlocks, eMolecules, Invitrogen, and SciTegic, where he served as executive consultant and acting COO until the company was acquired by Accelrys. Mr. Zarrabian currently serves on the board of biopharmaceutical company Ambit Biosciences, and chemistry eCommerce portal, eMolecules.

Zarrabian commented, “I am delighted to join a very talented team at Cyntellect as we focus on continuing our growth, and building upon the great momentum achieved to date. In the past year alone, Cyntellect has expanded dramatically into Europe and Asia, and has commercialized novel new products for applications in cell line development for biopharmaceuticals, drug discovery and cancer research, including key applications utilizing stem cells. I am also enthused about our strong collaborations which will help Cyntellect to drive high value solutions based on our LEAP™ Cell Processing Workstation and Celigo™ Adherent Cell Cytometer systems. The need to analyze cells easily, and to process cells with precision and efficiency are important challenges in the research community, and will remain a central focus for Cyntellect.”

“We welcome Saiid aboard. He brings to Cyntellect a perfect blend of technology, software, and product commercialization experience combined with a successful track record within the life sciences industry,” said Randal Kirk, chairman of Cyntellect’s Board of Directors.